KIM LLC’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

KIM LLC’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200,000	Closed	-$2.17M	–	439
2023 Q3	$2.17M	Hold	200,000	–	–	0.22%	89
2023 Q2	$2.13M	Sell	200,000 -150,000	-43%	-$1.58M	0.18%	114
2023 Q1	$3.65M	Sell	350,000 -150,000	-30%	-$1.55M	0.25%	102
2022 Q4	$5.14M	Hold	500,000	–	–	0.28%	58
2022 Q3	$5.02M	Hold	500,000	–	–	0.23%	74
2022 Q2	$5.03M	Buy	+500,000	New	+$4.96M	0.24%	69

KIM LLC's BIOS Position: Q4 2023 in Review

KIM LLC sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 200,000 shares — an estimated $2.17M sold.

KIM LLC first reported a position in BIOS in Q2 2022 and held it in 6 quarters. The position peaked at $5.14M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

KIM LLC reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
KIM LLC sold 200,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $2.17M.
KIM LLC first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 6 quarters.
KIM LLC's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $5.14M in Q4 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on KIM LLC's 13F filing for Q4 2023, filed 9 Feb 2024.